Real-life PET / CT abilities to assess activity and extension of sarcoidosis
https://doi.org/10.18093/0869-0189-2013-0-6-119-122
Abstract
Real-life PET / CT abilities to assess activity and extension of sarcoidosis.
About the Authors
A. A. Zaytsev
ФГКУ "Главный военный клинический госпиталь имени академика Н.Н.Бурденко" МО РФ
Russian Federation
Russian Federation
D. N. Antipushina
ФГКУ "Главный военный клинический госпиталь имени академика Н.Н.Бурденко" МО РФ
Russian Federation
Russian Federation
I. V. Sivokozov
ФГБУ "Центральный НИИ туберкулеза" РАМН
Russian Federation
Russian Federation
References
1. Чучалин А.Г., Визель А.А., Амиров Н.Б. (ред.). Саркоидоз. Учеб.-метод. пособие. Казань: Медицина, 2010.
2. Wells A., Hirani N., et al. Interstitial lung disease guideline: the British and the Irish Thoracic Society Thoracic Society of Australia and New Zealand Thoracic Society in collaboration with the Thoracic Society of Australia and Disease Guideline Group, a subgroup of the British Thoracic Society Standards. Thorax 2008; 63; 1–58.
3. Soussan M., Augier A., Brillet P. et al. Functional Imaging in Extrapulmonary Sarcoidosis: FDG-PET/CT and MR Features. Clin. Nucl. Med. 2013. Aviable at: http://journals.lww.com/nuclearmed/Abstract/publishahead/Functional-Imaging-in-Extrapulmonary-Sarcoidosis-.99737.aspx
4. Skali H., Schulman A., Dorbala S. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr. Cardiol. Rep. 2013; 15 (4): 352.
5. Ng D., Jacobs M., Mantil J. Combined C-11 methionine and F-18 FDG PET imaging in a case of neurosarcoidosis. Clin. Nucl. Med. 2006; 31 (7): 373–375.
6. Aide N., Benayoun M., Kerrou K. et al. Impact of [18F]-flu-orodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolicresponse to corticosteroid therapy. Br. J. Radiol. 2007; 80 (951): e67–e71.
7. Inoue K., Goto R., Shimomura H., Fukuda H. FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment. Springerplus 2013; 2 (1): 113.
8. Videnovic7Ivanov J., Vucinic7Mihailovic V., Artiko V. et al. Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis. Clin. Nucl. Med. 2013; 38 (7): 516–521.
9. Imperiale A., Riehm S., Braun J. Interest of [18F]FDG PET/CT for treatment efficacy assessment in aggressive phenotype of sarcoidosis with special emphasis on sinonasal involvement. Quart. J. Nucl. Med. Mol. Imag. 2013; 57 (2): 177–186.
10. Coker R. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs 2007; 67 (8): 1139–1147.
11. Ambrosini V., Zompatori M., Fasano L. et al. 18F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: Results of a Preliminary Prospective Study. Clin. Nucl. Med. 2013; 38 (4): e171–e177.
Review
For citations:
Zaytsev A.A., Antipushina D.N., Sivokozov I.V. Real-life PET / CT abilities to assess activity and extension of sarcoidosis. PULMONOLOGIYA. 2013;(6):119-122. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-6-119-122
Views:
1455
Email this article 